ArticlePLoS biology2016
Animal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and Barriers.
Article in PLoS biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- Risk of bias and reporting practices in studies comparing VOJournal of sport and health science · 2022Pooled it
- Rethinking 3R strategies: Digging deeper into AnimalTestInfo promotes transparency in in vivo biomedical research.PLoS biology · 2017Pooled it
- Preregistration of Preclinical Animal Studies as a Tool for Refinement: A Feasibility Study Comparing the German Animal Study Registry and Preclinicaltrials.eu.Animals : an open access journal from MDPI · 2026Article
- A survey of researchers' attitudes to preregistration in animal research reveals multiple perceived barriers to adoption.PLoS biology · 2026Article
- Interdisciplinary Animal Research Ethics-Challenges, Opportunities, and Perspectives.Animals : an open access journal from MDPI · 2024Article
- Supporting study registration to reduce research waste.Nature ecology & evolution · 2024Review
- A call to implement preclinical study registration in animal ethics review.PLoS biology · 2023Article
- Preregistration of animal research protocols: development and 3-year overview of preclinicaltrials.eu.BMJ open science · 2022Review
- Web-based survey among animal researchers on publication practices and incentives for increasing publication rates.PloS one · 2021Article
- Attitudes towards animal study registries and their characteristics: An online survey of three cohorts of animal researchers.PloS one · 2020Article
- Refining animal research: The Animal Study Registry.PLoS biology · 2019Article
- 3Rs missing: animal research without scientific value is unethical.BMJ open science · 2019Article
- Article
- Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study.British journal of pharmacology · 2018Article
- Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment?PLoS biology · 2018Article
- Arthritis models: usefulness and interpretation.Seminars in immunopathology · 2017Review
Corrections and comments
- Commented on by
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Publication bias in animal research, its extent, its predictors, and its potential countermeasures are increasingly discussed. Recent reports and conferences highlight the potential strengths of animal study registries (ASRs) in this regard. Others have warned that prospective registration of animal studies could diminish creativity, add administrative burdens, and complicate intellectual property issues in translational research. A literature review and 21 international key-informant interviews were conducted and thematically analyzed to develop a comprehensive matrix of main- and subcategories for potential ASR-related strengths, weaknesses, facilitators, and barriers (SWFBs). We identified 130 potential SWFBs. All stakeholder groups agreed that ASRs could in various ways improve the quality and refinement of animal studies while allowing their number to be reduced, as well as supporting meta-research on animal studies. However, all stakeholder groups also highlighted the potential for theft of ideas, higher administrative burdens, and reduced creativity and serendipity in animal studies. Much more detailed reasoning was captured in the interviews than is currently found in the literature, providing a comprehensive account of the issues and arguments around ASRs. All stakeholder groups highlighted compelling potential strengths of ASRs. Although substantial weaknesses and implementation barriers were highlighted as well, different governance measures might help to minimize or even eliminate their impact. Such measures might include confidentiality time frames for accessing prospectively registered protocols, harmonized reporting requirements across ASRs, ethics reviews, lab notebooks, and journal submissions. The comprehensive information gathered in this study could help to guide a more evidence-based debate and to design pilot tests for ASRs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.